| Name | Title | Contact Details |
|---|
Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients` lives through the discovery and commercialization of transformative tests to assess a person`s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad`s molecular diagnostic tests are based on an understanding of the role genes play in human disease and were developed with a commitment to improving an individual`s decision making process for monitoring and treating disease. Myriad is focused on strategic directives to introduce new products, including companion diagnostics, as well as expanding internationally.
Medarray is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S.
Copernicus is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Targacept`s clinical pipeline is built on a unique class of therapeutic targets.